Understanding Intra- and Inter-Species Variability in Neural Stem Cells' Biology Is Key to Their Successful Cryopreservation, Culture, and Propagation.
Klaudia RadoszkiewiczJezierska-Woźniak KatarzynaTomasz WaśniewskiAnna SarnowskaPublished in: Cells (2023)
Although clinical trials on human neural stem cells (hNSCs) have already been implemented in the treatment of neurological diseases and they have demonstrated their therapeutic effects, many questions remain in the field of preclinical research regarding the biology of these cells, their therapeutic properties, and their neurorestorative potential. Unfortunately, scientific reports are inconsistent and much of the NSCs research has been conducted on rodents rather than human cells for ethical reasons or due to insufficient cell material. Therefore, a question arises as to whether or which conclusions drawn on the isolation, cell survival, proliferation, or cell fate observed in vitro in rodent NSCs can be introduced into clinical applications. This paper presents the effects of different spatial, nutritional, and dissociation conditions on NSCs' functional properties, which are highly species-dependent. Our study confirmed that the discrepancies in the available literature on NSCs survival, proliferation, and fate did not only depend on intra-species factors and applied environmental conditions, but they were also affected by significant inter-species variability. Human and rodent NSCs share one feature, i.e., the necessity to be cultured immediately after isolation, which significantly maintains their survival. Additionally, in the absence of experiments on human cells, rat NSCs biology (neurosphere formation potential and neural differentiation stage) seems closer to that of humans rather than mice in response to environmental factors.
Keyphrases
- neural stem cells
- endothelial cells
- clinical trial
- signaling pathway
- cell fate
- induced apoptosis
- systematic review
- machine learning
- human health
- genetic diversity
- pluripotent stem cells
- cell cycle arrest
- type diabetes
- single cell
- metabolic syndrome
- cell death
- adipose tissue
- bone marrow
- combination therapy
- risk assessment
- cell proliferation
- phase iii
- placebo controlled
- neural network
- wild type